|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wroblewski LE, Peek RM Jr and Wilson KT:
Helicobacter pylori and gastric cancer: Factors that
modulate disease risk. Clin Microbiol Rev. 23:713–739. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li G, Wang Z, Wang Z, Xu J, Cui J, Cai S,
Zhan W and He Y: Gastric cancer patients with Helicobacter
pylori infection have a poor prognosis. J Surg Oncol.
108:421–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gherardi E and Stoker M: Hepatocyte growth
factor-scatter factor: Mitogen, motogen, and met. Cancer Cells.
3:227–232. 1991.PubMed/NCBI
|
|
5
|
Prat M, Narsimhan RP, Crepaldi T, Nicotra
MR, Natali PG and Comoglio PM: The receptor encoded by the human
c-MET oncogene is expressed in hepatocytes, epithelial cells and
solid tumors. Int J Cancer. 49:323–328. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou HY, Pon YL and Wong AS: HGF/MET
signaling in ovarian cancer. Curr Mol Med. 8:469–480. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hack SP, Bruey JM and Koeppen H:
HGF/MET-directed therapeutics in gastroesophageal cancer: A review
of clinical and biomarker development. Oncotarget. 5:2866–2880.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gelsomino F, Rossi G and Tiseo M: MET and
small-cell lung cancer. Cancers (Basel). 6:2100–2115. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sipos F and Galamb O:
Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
in the colon. World J Gastroenterol. 18:601–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis. The updated Sydney
System. International Workshop on the Histopathology of Gastritis,
Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marano L, Chiari R, Fabozzi A, De Vita F,
Boccardi V, Roviello G, Petrioli R, Marrelli D, Roviello F and
Patriti A: c-Met targeting in advanced gastric cancer: An open
challenge. Cancer Lett. 365:30–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakajima M, Sawada H, Yamada Y, Watanabe
A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T and
Nakano H: The prognostic significance of amplification and
overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Cancer. 85:1894–1902. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amemiya H, Kono K, Itakura J, Tang RF,
Takahashi A, An FQ, Kamei S, Iizuka H, Fujii H and Matsumoto Y:
c-Met expression in gastric cancer with liver metastasis. Oncology.
63:286–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Churin Y, Al-Ghoul L, Kepp O, Meyer TF,
Birchmeier W and Naumann M: Helicobacter pylori CagA protein
targets the c-Met receptor and enhances the motogenic response. J
Cell Biol. 161:249–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Franke R, Muller M, Wundrack N, Gilles ED,
Klamt S, Kähne T and Naumann M: Host-pathogen systems biology:
Logical modelling of hepatocyte growth factor and Helicobacter
pylori induced c-Met signal transduction. BMC Syst Biol.
2:42008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noguchi E, Saito N, Kobayashi M and
Kameoka S: Clinical significance of hepatocyte growth factor/c-Met
expression in the assessment of gastric cancer progression. Mol Med
Rep. 11:3423–3431. 2015.PubMed/NCBI
|
